Log in to save to my catalogue

Patient-derived organoids as a platform for modeling a patient’s response to chemoradiotherapy in es...

Patient-derived organoids as a platform for modeling a patient’s response to chemoradiotherapy in es...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_43bca536a467471b9f4d262b3322f68e

Patient-derived organoids as a platform for modeling a patient’s response to chemoradiotherapy in esophageal cancer

About this item

Full title

Patient-derived organoids as a platform for modeling a patient’s response to chemoradiotherapy in esophageal cancer

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2021-10, Vol.11 (1), p.21304-21304, Article 21304

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

3D patient-derived organoids (PDOs) have been utilized to evaluate potential therapies for patients with different cancers. However, the use of PDOs created from treatment-naive patient biopsies for prediction of clinical outcomes in patients with esophageal cancer has not yet been reported. Herein we describe a pilot prospective observational stud...

Alternative Titles

Full title

Patient-derived organoids as a platform for modeling a patient’s response to chemoradiotherapy in esophageal cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_43bca536a467471b9f4d262b3322f68e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_43bca536a467471b9f4d262b3322f68e

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-021-00706-8

How to access this item